Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.5300 (-1.04%) ($30.0900 - $31.7300) on Thu. Jul. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.77% (three month average) | RSI | 63 | Latest Price | $30.5300(-1.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) IWO(58%) ARKG(56%) IBUY(54%) IWC(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.385% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-13%) TBT(-6%) IYT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.385% (StdDev 4.77%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
5 Day Moving Average | $29.84(2.31%) | 10 Day Moving Average | $31.04(-1.64%) | 20 Day Moving Average | $29.75(2.62%) | To recent high | -11.1% | To recent low | 56.1% | Market Cap | $1.896b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |